As the Biden administration carves out its approach to healthcare policy, some healthcare thought leaders are reflecting on the successes and failures of recent experiments in payment reform. Voluntary alternative payment models (APMs) in a range of…
New payment models, New regulatory and reimbursement approaches, Health system readiness / Healthcare
The past year has been a remarkable one for nearly every company. The COVID-19 pandemic and associated disruptions resulted in unforeseeable performance outcomes for many companies. Senior executives spent large portions of their time addressing…
Managing the responsibilities of the audit committee is an evolving challenge for today’s audit chairs. Effective committee leadership is more important than ever, especially as proponents of governance reform continue to push for increased audit…
Board and committee effectiveness, Working with the internal and external auditor
The International Auditing and Assurance Standards Board (IAASB) develops auditing standards that can be adopted by audit regulators around the globe. It is a key player in determining how audit firms do their work, and it is continually trying to…
Accounting and financial reporting, Corporate and board regulatory matters, Working with the internal and external auditor
In 2013, the Sustainable Predictive Oncology Therapeutics and Diagnostics (SPOT/Dx) working group committed to developing a new approach to assess laboratory test validation and performance. Consequently, the Diagnostic Quality Assurance Pilot was…
Precision medicine and diagnostics / Healthcare
The rise to prominence of environmental, social, and governance issues (ESG) has caused boards to assess how best to oversee these matters. Investors and other stakeholders are calling for both concrete actions and heightened disclosures on a range…
Board and committee effectiveness, Board risk oversight, Investor perspectives on public companies
On January 28, 2021, Insurance Governance Leadership Network (IGLN) participants, including non-executive directors and other senior insurance leaders, were joined by EY’s insurance leaders to discuss priorities for insurance boards and management…
Governance, Regulation and supervision, Risk management and oversight / Insurance and Asset Management
A new frontier in cancer screening is leveraging liquid-based detection, which look for signals of cancer in blood, urine, or stool samples, to create multi- rather than single-cancer screens. For those organizations focused on advancing multicancer…
Precision medicine and diagnostics, Health system readiness / Healthcare
On January 21, 2021, Bank Governance Leadership Network (BGLN) participants, including non-executive directors and other senior banking leaders, were joined by EY’s banking and capital markets leaders to discuss priorities for bank boards and…
Governance, Regulation and supervision, Risk management and oversight / Banking
The COVID-19 pandemic accelerated technology transformations in large financial institutions, as employees moved to remote work and as customers shifted to digital channels. Customers have come to expect uninterrupted, personalized digital products…
Innovation and technology, Risk management and oversight, Financial Strategy / Banking, Innovation and technology, Risk management and oversight, Financial Strategy / Insurance and Asset Management